A contemporary re-evaluation of culprit lesion severity in patients presenting with STEMI

Liam M McCormick1, Stephen P Hoole, Adam J Brown

  • 1Department of Interventional Cardiology, Papworth Hospital, Cambridge, UK.

Acute Cardiac Care
|December 11, 2012
PubMed

Insights

ST-segment elevation myocardial infarction (STEMI) culprit lesions are angiographically significant, similar to stable lesions. This study re-evaluated stenosis severity in STEMI patients, finding anatomical severity comparable to stable coronary artery disease.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Historical data link plaque rupture to myocardial infarction, but recent studies highlight hemodynamically significant stenoses (FFR ≤ 0.8) and high plaque burden (MLA < 4 mm² by IVUS) as prognostically important.
  • The prognostic significance of culprit stenosis severity in ST-segment elevation myocardial infarction (STEMI) requires re-evaluation.

Purpose of the Study:

  • To re-evaluate the severity of culprit stenosis in patients presenting with STEMI.
  • To compare the anatomical and functional significance of culprit lesions in STEMI with stable coronary artery disease.

Main Methods:

  • Quantitative coronary angiography (QCA) was performed after thrombus aspiration in 336 STEMI patients undergoing primary percutaneous coronary intervention (PPCI).
  • Measurements included reference area (RA), minimum luminal area (MLA), and percentage area stenosis (AS).
  • QCA and fractional flow reserve (FFR) were measured in 50 stable angina patients with intermediate lesions for validation.

Main Results:

  • STEMI culprit lesions showed similar anatomical severity (AS: 91.6 ± 9.5%) compared to stable lesions (AS: 90.1 ± 8.1%).
  • Angiographically severe lesions were more likely to be functionally significant by FFR (P = 0.02).
  • Functionally significant lesions were more likely to be anatomically severe (P = 0.002).

Conclusions:

  • Contemporary data indicate that STEMI culprit lesions, assessed by luminal stenosis post-thrombus aspiration, are angiographically significant.
  • The severity of these STEMI lesions is comparable to stable, ischemia-inducing lesions.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...